SPACA3
gene geneOn this page
Also known as ALLP17SLLP1LYC3LYZL3CT54
Summary
SPACA3 (sperm acrosome associated 3, HGNC:16260) is a protein-coding gene on chromosome 17q11.2, encoding Sperm acrosome membrane-associated protein 3 (Q8IXA5). Sperm surface membrane protein that may be involved in sperm-egg plasma membrane adhesion and fusion during fertilization.
The protein encoded by this gene is a sperm surface protein that may be involved in adhesion to the egg prior to fertilization. While the encoded protein has significant similarity to lysozyme at the amino acid level, it has no detectable bacteriocidal activity. Several transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 124912 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 52 total
- MANE Select transcript:
NM_173847
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16260 |
| Approved symbol | SPACA3 |
| Name | sperm acrosome associated 3 |
| Location | 17q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ALLP17, SLLP1, LYC3, LYZL3, CT54 |
| Ensembl gene | ENSG00000141316 |
| Ensembl biotype | protein_coding |
| OMIM | 612749 |
| Entrez | 124912 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000269053, ENST00000394637, ENST00000394638, ENST00000485015, ENST00000580599
RefSeq mRNA: 3 — MANE Select: NM_173847
NM_001317225, NM_001317226, NM_173847
CCDS: CCDS11275, CCDS82105
Canonical transcript exons
ENST00000269053 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000947759 | 32996843 | 32997001 |
| ENSE00003573647 | 32995409 | 32995717 |
| ENSE00003639885 | 32997445 | 32997523 |
| ENSE00003660266 | 32997712 | 32997877 |
| ENSE00003849782 | 32991847 | 32991972 |
Expression profiles
Bgee: expression breadth ubiquitous, 112 present calls, max score 96.39.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0486 / max 57.2878, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 160271 | 0.0305 | 3 |
| 160272 | 0.0108 | 3 |
| 160270 | 0.0073 | 3 |
Top tissues by expression
235 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 96.39 | gold quality |
| right testis | UBERON:0004534 | 96.28 | gold quality |
| sperm | CL:0000019 | 94.96 | gold quality |
| testis | UBERON:0000473 | 93.17 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.73 | gold quality |
| adult organism | UBERON:0007023 | 75.85 | gold quality |
| body of pancreas | UBERON:0001150 | 71.98 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 68.95 | gold quality |
| buccal mucosa cell | CL:0002336 | 66.38 | gold quality |
| tibialis anterior | UBERON:0001385 | 65.84 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 63.27 | gold quality |
| pancreas | UBERON:0001264 | 61.67 | gold quality |
| myocardium | UBERON:0002349 | 60.22 | gold quality |
| pancreatic ductal cell | CL:0002079 | 59.93 | silver quality |
| endothelial cell | CL:0000115 | 59.46 | gold quality |
| parotid gland | UBERON:0001831 | 58.67 | gold quality |
| deltoid | UBERON:0001476 | 56.03 | silver quality |
| ileal mucosa | UBERON:0000331 | 55.24 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 54.64 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| medial globus pallidus | UBERON:0002477 | 52.93 | gold quality |
| cerebellar vermis | UBERON:0004720 | 52.03 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 51.92 | gold quality |
| globus pallidus | UBERON:0001875 | 50.91 | gold quality |
| quadriceps femoris | UBERON:0001377 | 48.99 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 48.46 | gold quality |
| amniotic fluid | UBERON:0000173 | 47.63 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.13 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 5)
- SLLP1 could be a potential receptor for the egg oligosaccharide residue N-acetylglucosamine, which is present in the extracellular matrix over the egg plasma membrane (PMID:12606493)
- SLLP1 is capable of eliciting B-cell immune responses in vivo in cancer-bearing individuals. (PMID:15475442)
- Authors present evidence that the variants could affect the expression levels or function of SPRASA, thereby affecting a couple’s fertility. (PMID:24872021)
- The levels of antibodies reactive with SPRASA were elevated in infertile women. (PMID:25038051)
- SLLP1 represents a promising target for the immunotherapy of multiple myeloma. (PMID:26088750)
Cross-species orthologs
13 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spaca3 | ENSMUSG00000053184 |
| rattus_norvegicus | Spaca3 | ENSRNOG00000006994 |
| drosophila_melanogaster | LysB | FBGN0004425 |
| drosophila_melanogaster | LysD | FBGN0004427 |
| drosophila_melanogaster | LysE | FBGN0004428 |
| drosophila_melanogaster | LysP | FBGN0004429 |
| drosophila_melanogaster | LysS | FBGN0004430 |
| drosophila_melanogaster | LysX | FBGN0004431 |
| drosophila_melanogaster | CG16756 | FBGN0029765 |
| drosophila_melanogaster | CG7798 | FBGN0034092 |
| drosophila_melanogaster | CG16799 | FBGN0034538 |
| drosophila_melanogaster | CG11159 | FBGN0034539 |
| drosophila_melanogaster | CG30062 | FBGN0050062 |
Paralogs (8): LYZ (ENSG00000090382), LYZL1 (ENSG00000120563), LYZL2 (ENSG00000151033), LYZL4 (ENSG00000157093), LALBA (ENSG00000167531), SPACA5B (ENSG00000171478), SPACA5 (ENSG00000171489), LYZL6 (ENSG00000275722)
Protein
Protein identifiers
Sperm acrosome membrane-associated protein 3 — Q8IXA5 (reviewed: Q8IXA5)
Alternative names: Cancer/testis antigen 54, Lysozyme-like acrosomal sperm-specific secretory protein ALLP-17, Lysozyme-like protein 3, Sperm lysozyme-like protein 1, Sperm protein reactive with antisperm antibodies
All UniProt accessions (3): A0A080YUZ7, E9PF91, Q8IXA5
UniProt curated annotations — full annotation on UniProt →
Function. Sperm surface membrane protein that may be involved in sperm-egg plasma membrane adhesion and fusion during fertilization. It could be a potential receptor for the egg oligosaccharide residue N-acetylglucosamine, which is present in the extracellular matrix over the egg plasma membrane. The processed form has no detectable bacteriolytic activity in vitro.
Subunit / interactions. Interacts with ASTL.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome membrane Secreted.
Tissue specificity. The processed form is expressed in sperm (at protein level). Expressed in testis, epididymis and placenta.
Post-translational modifications. The processed form derives from the membrane form by proteolytic processing.
Similarity. Belongs to the glycosyl hydrolase 22 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IXA5-1 | 1 | yes |
| Q8IXA5-2 | 2 |
RefSeq proteins (3): NP_001304154, NP_001304155, NP_776246* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000974 | Glyco_hydro_22_lys | Family |
| IPR001916 | Glyco_hydro_22 | Family |
| IPR019799 | Glyco_hydro_22_CS | Domain |
| IPR023346 | Lysozyme-like_dom_sf | Homologous_superfamily |
Pfam: PF00062
UniProt features (15 total): disulfide bond 4, sequence variant 3, chain 2, topological domain 2, splice variant 1, transmembrane region 1, domain 1, site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IXA5-F1 | 82.40 | 0.63 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 87–88 (cleavage; to produce processed form)
Disulfide bonds (4): 162–180, 93–213, 117–201, 151–166
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 83 (showing top):
GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_SINGLE_FERTILIZATION, GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS, GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION, GOCC_SECRETORY_GRANULE, GOBP_MEMBRANE_FUSION, GOBP_PLASMA_MEMBRANE_ORGANIZATION, GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION, GOBP_VESICLE_MEDIATED_TRANSPORT, chr17q11, GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT, GOBP_MYELOID_LEUKOCYTE_ACTIVATION, WANG_RECURRENT_LIVER_CANCER_DN, GOBP_SPERM_EGG_RECOGNITION, GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION
GO Biological Process (5): fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342), sperm-egg recognition (GO:0035036), monocyte activation (GO:0042117), positive regulation of macrophage activation (GO:0043032), positive regulation of phagocytosis (GO:0050766)
GO Molecular Function (2): lysozyme activity (GO:0003796), protein binding (GO:0005515)
GO Cellular Component (8): acrosomal vesicle (GO:0001669), acrosomal membrane (GO:0002080), extracellular region (GO:0005576), secretory granule (GO:0030141), sperm flagellum (GO:0036126), acrosomal matrix (GO:0043159), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| single fertilization | 2 |
| acrosomal vesicle | 2 |
| cellular process involved in reproduction in multicellular organism | 1 |
| cell-cell recognition | 1 |
| myeloid leukocyte activation | 1 |
| positive regulation of leukocyte activation | 1 |
| macrophage activation | 1 |
| regulation of macrophage activation | 1 |
| phagocytosis | 1 |
| positive regulation of endocytosis | 1 |
| regulation of phagocytosis | 1 |
| hydrolase activity, hydrolyzing O-glycosyl compounds | 1 |
| peptidoglycan muralytic activity | 1 |
| binding | 1 |
| secretory granule | 1 |
| secretory granule membrane | 1 |
| endomembrane system | 1 |
| secretory vesicle | 1 |
| 9+2 motile cilium | 1 |
| vacuole | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
654 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPACA3 | SPACA1 | Q9HBV2 | 702 |
| SPACA3 | TMEM190 | Q8WZ59 | 639 |
| SPACA3 | IZUMO1 | Q8IYV9 | 576 |
| SPACA3 | SPESP1 | Q6UW49 | 573 |
| SPACA3 | ACRBP | Q8NEB7 | 561 |
| SPACA3 | ZPBP | Q9BS86 | 560 |
| SPACA3 | LUZP4 | Q9P127 | 552 |
| SPACA3 | HSPB3 | Q12988 | 549 |
| SPACA3 | CCDC110 | Q8TBZ0 | 544 |
| SPACA3 | MPEG1 | Q2M385 | 522 |
| SPACA3 | ZNF165 | P49910 | 507 |
| SPACA3 | ASTL | Q6HA08 | 505 |
| SPACA3 | SPMAP2 | Q9P2T0 | 472 |
| SPACA3 | PRM2 | P04554 | 469 |
| SPACA3 | LTF | P02788 | 462 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPACA3 | HSPA5 | psi-mi:“MI:0914”(association) | 0.530 |
| ZP3 | SPACA3 | psi-mi:“MI:0915”(physical association) | 0.490 |
| SPACA3 | A2M | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (10): FKBP14 (Affinity Capture-MS), AADAT (Affinity Capture-MS), FKBP7 (Affinity Capture-MS), HSPA5 (Affinity Capture-MS), ANKRD46 (Affinity Capture-MS), FKBP14 (Affinity Capture-MS), HSPA5 (Affinity Capture-MS), AADAT (Affinity Capture-MS), FKBP7 (Affinity Capture-MS), SPACA3 (Two-hybrid)
ESM2 similar proteins: A2AE20, A6QQ77, B6VH75, B6VH76, B6VH77, B6VH79, D4ABW7, O08717, O15496, O75173, O75951, O88839, P00716, P01231, P04421, P04651, P09462, P11688, P12068, P30805, P51782, Q05820, Q0V8J4, Q13444, Q29RT1, Q2T9N7, Q32PD6, Q49KI5, Q5E985, Q5RFQ8, Q5U2X4, Q659U0, Q659U1, Q659U5, Q6EV78, Q6MG64, Q8BNJ2, Q8IXA5, Q923K1, Q96KX0
Diamond homologs: A0JNM6, A2AE20, A6QQ77, B6VH75, B6VH76, G3XDT7, O75951, P00697, P00698, P00699, P00700, P00701, P00702, P00703, P00704, P00705, P00706, P00707, P00708, P04421, P08905, P11375, P11376, P11941, P12066, P12067, P12068, P12069, P16973, P17607, P17897, P19849, P22910, P24364, P24533, P30201, P37712, P37713, P49663, P61626
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 5 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
740 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:32996841:AGG:A | acceptor_gain | 1.0000 |
| 17:32996842:GGG:G | acceptor_gain | 1.0000 |
| 17:32996866:A:G | acceptor_gain | 1.0000 |
| 17:32996943:G:GT | donor_gain | 1.0000 |
| 17:32996988:G:GT | donor_gain | 1.0000 |
| 17:32996997:CTCAG:C | donor_loss | 1.0000 |
| 17:32997000:AG:A | donor_loss | 1.0000 |
| 17:32997001:GG:G | donor_loss | 1.0000 |
| 17:32997002:G:A | donor_loss | 1.0000 |
| 17:32997003:T:A | donor_loss | 1.0000 |
| 17:32997438:A:AG | acceptor_gain | 1.0000 |
| 17:32997439:C:G | acceptor_gain | 1.0000 |
| 17:32997441:CCAG:C | acceptor_loss | 1.0000 |
| 17:32997442:CA:C | acceptor_loss | 1.0000 |
| 17:32997443:A:AG | acceptor_gain | 1.0000 |
| 17:32997443:AG:A | acceptor_loss | 1.0000 |
| 17:32997444:G:GG | acceptor_gain | 1.0000 |
| 17:32997444:GAT:G | acceptor_gain | 1.0000 |
| 17:32997444:GATT:G | acceptor_gain | 1.0000 |
| 17:32997444:GATTT:G | acceptor_gain | 1.0000 |
| 17:32997520:ACTGG:A | donor_loss | 1.0000 |
| 17:32997524:G:GC | donor_loss | 1.0000 |
| 17:32997525:TAA:T | donor_loss | 1.0000 |
| 17:32991973:G:GG | donor_gain | 0.9900 |
| 17:32995718:G:GG | donor_gain | 0.9900 |
| 17:32996838:TGCAG:T | acceptor_loss | 0.9900 |
| 17:32996840:CAGGG:C | acceptor_loss | 0.9900 |
| 17:32996841:A:T | acceptor_loss | 0.9900 |
| 17:32996841:AG:A | acceptor_gain | 0.9900 |
| 17:32996842:GG:G | acceptor_gain | 0.9900 |
AlphaMissense
1391 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:32997712:G:C | W194C | 0.993 |
| 17:32997712:G:T | W194C | 0.993 |
| 17:32997757:G:C | W209C | 0.993 |
| 17:32997757:G:T | W209C | 0.993 |
| 17:32996927:T:G | F143C | 0.990 |
| 17:32997721:G:C | W197C | 0.988 |
| 17:32997721:G:T | W197C | 0.988 |
| 17:32996949:G:C | W150C | 0.984 |
| 17:32996949:G:T | W150C | 0.984 |
| 17:32996844:G:C | W115C | 0.981 |
| 17:32996844:G:T | W115C | 0.981 |
| 17:32996927:T:C | F143S | 0.981 |
| 17:32997731:T:A | C201S | 0.978 |
| 17:32997732:G:C | C201S | 0.978 |
| 17:32996950:T:A | C151S | 0.976 |
| 17:32996951:G:C | C151S | 0.976 |
| 17:32997475:T:A | V178D | 0.975 |
| 17:32996933:T:C | I145T | 0.972 |
| 17:32996938:A:C | S147R | 0.972 |
| 17:32996940:C:A | S147R | 0.972 |
| 17:32996940:C:G | S147R | 0.972 |
| 17:32997480:T:A | C180S | 0.972 |
| 17:32997481:G:C | C180S | 0.972 |
| 17:32996867:G:T | S123I | 0.971 |
| 17:32996921:G:T | G141V | 0.971 |
| 17:32996921:G:A | G141E | 0.970 |
| 17:32997767:T:A | C213S | 0.969 |
| 17:32997768:G:C | C213S | 0.969 |
| 17:32996860:T:C | F121L | 0.968 |
| 17:32996862:C:A | F121L | 0.968 |
dbSNP variants (sampled 300 via entrez): RS1000081754 (17:32994532 T>C), RS1000543372 (17:32997068 T>A), RS1001159677 (17:32995082 C>T), RS1001583447 (17:32997596 C>T), RS1001743826 (17:32991044 G>A), RS1001906362 (17:32997379 A>T), RS1002107030 (17:32991824 C>A,T), RS1002174878 (17:32990777 C>A,T), RS1002974848 (17:32992279 C>T), RS1002991542 (17:32996514 G>A), RS1003153265 (17:32989945 A>T), RS1003305211 (17:32993221 G>A), RS1004114973 (17:32993453 G>A,T), RS1004984526 (17:32997633 T>C), RS1005120524 (17:32991279 C>T)
Disease associations
OMIM: gene MIM:612749 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007682_2 | Thyroxine levels | 5.000000e-07 |
| GCST008368_3 | Plasma anti-thyroid peroxidase levels | 9.000000e-07 |
| GCST010002_122 | Refractive error | 7.000000e-44 |
| GCST90002404_157 | Red cell distribution width | 4.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009188 | Red cell distribution width |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.